HLVX
HilleVax
HLVX
HLVX
Delisted
HLVX was delisted on the 16th of September, 2025.
76 hedge funds and large institutions have $88.7M invested in HilleVax in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
-3
Holders Change %
-3.8%
% of All Funds
1.01%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
10
Increased
32
Reduced
15
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$938K |
| 2 |
Morgan Stanley
New York
|
+$902K |
| 3 |
JPMorgan Chase & Co
New York
|
+$400K |
| 4 |
Millennium Management
New York
|
+$318K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$274K |
Top Sellers
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$1.87M |
| 2 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$827K |
| 3 |
TC
Trium Capital
London,
United Kingdom
|
-$798K |
| 4 |
AC
Almitas Capital
Santa Monica,
California
|
-$470K |
| 5 |
CP
Catalys Pacific
Tokyo,
Japan
|
-$416K |
